Literature DB >> 9310472

Skewed X-inactivation in carriers of X-linked dyskeratosis congenita.

T J Vulliamy1, S W Knight, I Dokal, P J Mason.   

Abstract

A gene causing Dyskeratosis Congenita (DC), a rare genetic disorder associated with bone marrow failure, has been mapped to chromosome Xq28, but autosomal inheritance of the disease has also been reported. We have investigated the pattern of X-inactivation in the peripheral blood of carriers of DC using the methylation-sensitive Hpa II site in the androgen receptor gene (HUMARA). In 5 different families in which the inheritance of DC appears to be X-linked, all 16 carriers showed skewed X-inactivation patterns. These cases indicate that, in the hematopoiesis of heterozygous females, cells expressing the normal DC allele have a growth advantage over cells that express the mutant allele. In 7 other families with sporadic cases of DC or with an uncertain pattern of inheritance, both skewed and normal patterns of X-inactivation were observed. In these families or where crucial family members are unavailable, the study of X-inactivation patterns will add to linkage analysis in providing information about carrier status.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9310472

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  24 in total

1.  Segregation of a totally skewed pattern of X chromosome inactivation in four familial cases of Rett syndrome without MECP2 mutation: implications for the disease.

Authors:  L Villard; N Lévy; F Xiang; A Kpebe; V Labelle; C Chevillard; Z Zhang; C E Schwartz; M Tardieu; J Chelly; M Anvret; M Fontès
Journal:  J Med Genet       Date:  2001-07       Impact factor: 6.318

2.  Pseudouridylation defect due to DKC1 and NOP10 mutations causes nephrotic syndrome with cataracts, hearing impairment, and enterocolitis.

Authors:  Eszter Balogh; Jennifer C Chandler; Máté Varga; Mona Tahoun; Dóra K Menyhárd; Gusztáv Schay; Tomas Goncalves; Renáta Hamar; Regina Légrádi; Ákos Szekeres; Olivier Gribouval; Robert Kleta; Horia Stanescu; Detlef Bockenhauer; Andrea Kerti; Hywel Williams; Veronica Kinsler; Wei-Li Di; David Curtis; Maria Kolatsi-Joannou; Hafsa Hammid; Anna Szőcs; Kristóf Perczel; Erika Maka; Gergely Toldi; Florentina Sava; Christelle Arrondel; Magdolna Kardos; Attila Fintha; Ahmed Hossain; Felipe D'Arco; Mario Kaliakatsos; Jutta Koeglmeier; William Mifsud; Mariya Moosajee; Ana Faro; Eszter Jávorszky; Gábor Rudas; Marwa H Saied; Salah Marzouk; Kata Kelen; Judit Götze; George Reusz; Tivadar Tulassay; François Dragon; Géraldine Mollet; Susanne Motameny; Holger Thiele; Guillaume Dorval; Peter Nürnberg; András Perczel; Attila J Szabó; David A Long; Kazunori Tomita; Corinne Antignac; Aoife M Waters; Kálmán Tory
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-17       Impact factor: 11.205

Review 3.  X chromosome inactivation in clinical practice.

Authors:  Karen Helene Orstavik
Journal:  Hum Genet       Date:  2009-04-25       Impact factor: 4.132

4.  Somatic mutations in telomerase promoter counterbalance germline loss-of-function mutations.

Authors:  Lindley Maryoung; Yangbo Yue; Ashley Young; Chad A Newton; Cindy Barba; Nicolai S C van Oers; Richard C Wang; Christine Kim Garcia
Journal:  J Clin Invest       Date:  2017-02-13       Impact factor: 14.808

Review 5.  Concise Review: Age-Related Clonal Hematopoiesis: Stem Cells Tempting the Devil.

Authors:  Lambert Busque; Manuel Buscarlet; Luigina Mollica; Ross L Levine
Journal:  Stem Cells       Date:  2018-06-08       Impact factor: 6.277

6.  1.4 Mb candidate gene region for X linked dyskeratosis congenita defined by combined haplotype and X chromosome inactivation analysis.

Authors:  S W Knight; T J Vulliamy; N S Heiss; G Matthijs; K Devriendt; J M Connor; M D'Urso; A Poustka; P J Mason; I Dokal
Journal:  J Med Genet       Date:  1998-12       Impact factor: 6.318

7.  Investigation of chromosome X inactivation and clinical phenotypes in female carriers of DKC1 mutations.

Authors:  Jialin Xu; Payal P Khincha; Neelam Giri; Blanche P Alter; Sharon A Savage; Judy M Y Wong
Journal:  Am J Hematol       Date:  2016-11-04       Impact factor: 10.047

8.  Clonal hematopoiesis in patients with dyskeratosis congenita.

Authors:  Nieves Perdigones; Juan C Perin; Irene Schiano; Peter Nicholas; Jaclyn A Biegel; Philip J Mason; Daria V Babushok; Monica Bessler
Journal:  Am J Hematol       Date:  2016-10-21       Impact factor: 10.047

9.  Atypical X-chromosome inactivation in an X;1 translocation patient demonstrating Xq28 functional disomy.

Authors:  Catherine E Cottrell; Annemarie Sommer; Gail D Wenger; Steven Bullard; Tamara Busch; Katherine Nash Krahn; Andrew C Lidral; Julie M Gastier-Foster
Journal:  Am J Med Genet A       Date:  2009-03       Impact factor: 2.802

Review 10.  Dyskeratosis congenita, stem cells and telomeres.

Authors:  Michael Kirwan; Inderjeet Dokal
Journal:  Biochim Biophys Acta       Date:  2009-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.